Regina Mendrzyk

Actively personalized vaccination trial for newly diagnosed glioblastoma

Norbert Hilf, Sabrina Kuttruff-Coqui, Katrin Frenzel et al. · Nature · 2018 · 932 citations · Full text

Medicine, Biomedical Sciences, Oncology +12

Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival

Steffen Walter, Toni Weinschenk, Arnulf Stenzl et al. · Nature Medicine · 2012 · 784 citations

Medicine, Immunology, Oncology +17

IMA901, a multipeptide cancer vaccine, plus sunitinib versus sunitinib alone, as first-line therapy for advanced or metastatic renal cell carcinoma (IMPRINT): a multicentre, open-label, randomised, controlled, phase 3 trial

Brian I. Rini, Arnulf Stenzl, Romauld Zdrojowy et al. · The Lancet Oncology · 2016 · 216 citations

Medicine, Immunology, Oncology +14

Autologous T cell therapy for PRAME+ advanced solid tumors in HLA-A*02+ patients: a phase 1 trial

Martin Wermke, Dejka M Araurjo, Manik Chatterjee et al. · Nature Medicine · 2025 · 46 citations · Full text

Life Sciences, Immunology, Oncology +17

17LBA Results from an open-label, randomized, controlled Phase 3 study investigating IMA901 multipeptide cancer vaccine in patients receiving sunitinib as first-line therapy for advanced/metastatic RCC

Brian I. Rini, A. Stenzl, Romuald Zdrojowy et al. · European Journal of Cancer · 2015 · 21 citations

Medicine, Oncology, Pharmacology +17